These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1466 related items for PubMed ID: 31186013

  • 1. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
    Yang H, Lv H, Li H, Ci X, Peng L.
    Cell Commun Signal; 2019 Jun 11; 17(1):62. PubMed ID: 31186013
    [Abstract] [Full Text] [Related]

  • 2. Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in mice.
    Yang H, Huang J, Gao Y, Wen Z, Peng L, Ci X.
    Inflammopharmacology; 2020 Apr 11; 28(2):513-523. PubMed ID: 31552548
    [Abstract] [Full Text] [Related]

  • 3. Orientin relieves lipopolysaccharide-induced acute lung injury in mice: The involvement of its anti-inflammatory and anti-oxidant properties.
    Xiao Q, Cui Y, Zhao Y, Liu L, Wang H, Yang L.
    Int Immunopharmacol; 2021 Jan 11; 90():107189. PubMed ID: 33214095
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of endotoxin-induced acute lung injury in rats by bone marrow-derived mesenchymal stem cells: Role of Nrf2/HO-1 signal axis in inhibition of NLRP3 activation.
    Lei L, Guo Y, Lin J, Lin X, He S, Qin Z, Lin Q.
    Biochem Biophys Res Commun; 2021 Apr 30; 551():7-13. PubMed ID: 33713981
    [Abstract] [Full Text] [Related]

  • 5. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H, Chen S, Zeng M, Lin D, Wang Y, Wen X, Xu C, Yang L, Fan X, Gong Y, Zhang H, Kong X.
    Cell Physiol Biochem; 2018 Apr 30; 49(5):1918-1932. PubMed ID: 30235451
    [Abstract] [Full Text] [Related]

  • 6. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
    Lu Y, Yu T, Liu J, Gu L.
    PLoS One; 2018 Apr 30; 13(4):e0196405. PubMed ID: 29694408
    [Abstract] [Full Text] [Related]

  • 7. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation.
    Liu H, Lin Z, Ma Y.
    Biomed Pharmacother; 2020 May 30; 125():109943. PubMed ID: 32106380
    [Abstract] [Full Text] [Related]

  • 8. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
    Lv H, Yu Z, Zheng Y, Wang L, Qin X, Cheng G, Ci X.
    Int J Biol Sci; 2016 May 30; 12(1):72-86. PubMed ID: 26722219
    [Abstract] [Full Text] [Related]

  • 9. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
    Qiu YL, Cheng XN, Bai F, Fang LY, Hu HZ, Sun DQ.
    Biomed Pharmacother; 2018 Oct 30; 106():192-199. PubMed ID: 29958143
    [Abstract] [Full Text] [Related]

  • 10. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis.
    Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X.
    Redox Biol; 2017 Aug 30; 12():311-324. PubMed ID: 28285192
    [Abstract] [Full Text] [Related]

  • 11. Oridonin attenuates hind limb ischemia-reperfusion injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation.
    Zhao X, Liu Y, Wang L, Yan C, Liu H, Zhang W, Zhao H, Cheng C, Chen Z, Xu T, Li K, Cai J, Qiao T.
    J Ethnopharmacol; 2022 Jun 28; 292():115206. PubMed ID: 35301099
    [Abstract] [Full Text] [Related]

  • 12. Digitoflavone (DG) attenuates LPS-induced acute lung injury through reducing oxidative stress and inflammatory response dependent on the suppression of TXNIP/NLRP3 and NF-κB.
    Meng M.
    Biomed Pharmacother; 2017 Oct 28; 94():712-725. PubMed ID: 28800542
    [Abstract] [Full Text] [Related]

  • 13. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y, Huang L, Zhu G, Pei Z, Zhang W.
    J Cell Physiol; 2019 May 28; 234(5):6023-6032. PubMed ID: 30584668
    [Abstract] [Full Text] [Related]

  • 14. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
    Pei X, Zhang XJ, Chen HM.
    Biochem Biophys Res Commun; 2019 Aug 13; 516(1):270-277. PubMed ID: 31248593
    [Abstract] [Full Text] [Related]

  • 15. Isoorientin protects lipopolysaccharide-induced acute lung injury in mice via modulating Keap1/Nrf2-HO-1 and NLRP3 inflammasome pathways.
    Zhang L, Zhu XZ, Badamjav R, Zhang JZ, Kou JP, Yu BY, Li F.
    Eur J Pharmacol; 2022 Feb 15; 917():174748. PubMed ID: 34999086
    [Abstract] [Full Text] [Related]

  • 16. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS- and/or NF-κB-mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway.
    Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, Deng X, Xie Z, Zheng S.
    J Neuroinflammation; 2017 Jun 13; 14(1):119. PubMed ID: 28610608
    [Abstract] [Full Text] [Related]

  • 17. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-κB Signaling Pathway.
    Tang Y, Ding F, Wu C, Liu B.
    Anal Cell Pathol (Amst); 2021 Jun 13; 2021():6653681. PubMed ID: 34426780
    [Abstract] [Full Text] [Related]

  • 18. Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor 2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB Pathway in Macrophages and in Acute Lung Injury.
    Liu Q, Lv H, Wen Z, Ci X, Peng L.
    Front Immunol; 2017 Jun 13; 8():1518. PubMed ID: 29163554
    [Abstract] [Full Text] [Related]

  • 19. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R, Xia T, Wang Y, Ding Z, Li W, Chen Y, Peng M, Li C, Zhang H, Shu Z.
    J Ethnopharmacol; 2022 Feb 10; 284():114777. PubMed ID: 34737012
    [Abstract] [Full Text] [Related]

  • 20. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
    Mo M, Li S, Dong Z, Li C, Sun Y, Li A, Zhao Z.
    Int Immunopharmacol; 2020 Apr 10; 81():106273. PubMed ID: 32070920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.